Is a Positive NECPAL in ICU Patients Associated With Higher Mortality

NCT07007156 · tracked via the Priya Life Science Spain tracker

Sponsor

Consorci Sanitari de l'Alt Penedès i Garraf

Phase

Observational

Started

2025-06-12

Last updated

2025-12-05

Condition(s) studied

Acute Disease

Investigational drug(s) / intervention(s)

NECPAL positive

NECPAL positive: This group has a positive result for NECPAL scale

Study summary

The aim of the present study is to evaluate the usefulness of the NECPAL scale in identifying Intensive Care Unit (ICU)-admitted patients at higher risk of dying within 90 days of ICU admission

Eligibility

Sex

ALL

Min age

75 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Patients who meet all of the following inclusion criteria may be included in the study: * Men and women aged 75 years or older. * Admission to the ICU of the study center. * Legal capacity to provide informed consent. * Signed informed consent for study inclusion, either by the participant or their legal representative. Exclusion Criteria: Participants who meet any of the following exclusion criteria may not be included in the study: -Death within the first 24 hours of ICU admission.

Primary outcome measure(s)

Mortality — From baseline to 90-day
Patients who dye at 90-day from ICU admission

Trial sites (1)

Facility	City	Region	Status
CSAPG	Sant Pere de Ribes	Barcelona	Recruiting

More Consorci Sanitari de l'Alt Penedès i Garraf trials in Spain

Impact of Humor Prescription on the Emotional Well-being of Patients With Medically Unexplained Symptoms: A Quasi-experimental Study Active, not recruiting

Predictive Model for Mortality in Older People With Critical Illness Recruiting

Tapping Test and the Archimedean Spiral for the Differential Diagnosis of Tremor. Machine Learning Approach Recruiting

Introducing Electronic Alerts to Reduce Inappropriate Digoxin Prescribing in Older Adults Starting soon

High-risk Antithrombotic Drugs at Discharge and Consultation for Hemorrhagic or Thromboembolic Events in the Emergency Department Starting soon

Other trials for the same condition

High-risk Antithrombotic Drugs at Discharge and Consultation for Hemorrhagic or Thromboembolic Events in the Emergency Department Starting soon

Levels of Diagnostic and Therapeutic Intervention in Hospitalized Patients Starting soon

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07007156 on ClinicalTrials.gov ↗ ← All trials in Spain